Notes
cytotoxic T lymphocyte antigen 4
2015 US dollars
Reference
Mason NT, et al. Modeling the cost of immune checkpoint inhibitor-related toxicities. 52nd Annual Meeting of the American Society of Clinical Oncology : (plus poster) abstr. 6627, 3 Jun 2016. Available from: URL: http://meetinglibrary.asco.org/content/168780-176
Rights and permissions
About this article
Cite this article
Checkpoint inhibitors: costs of managing toxicities similar. PharmacoEcon Outcomes News 758, 14 (2016). https://doi.org/10.1007/s40274-016-3243-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3243-6